Bergot E - Search Results

1

[Prognostic and predictive biomarkers in non-small cell lung cancers. From conditioned registrations to routine molecular mapping of lung cancers: Methodological issues].

Bergot E, Levallet G, Creveuil C, Lechapt E, Zalcman G. Bergot E, et al. Presse Med. 2011 Apr;40(4 Pt 1):379-88. doi: 10.1016/j.lpm.2011.01.016. Epub 2011 Mar 3. Presse Med. 2011. PMID: 21376511 Review. French.

2

Pulmonary Artery Embolization in the Management of Hemoptysis Related to Lung Tumors.

Claudinot A, Douane F, Morla O, Perret C, Neveu M, Thouveny F, Bouvier A, Hureaux J, Le Guen A, Jouan J, Heautot JF, Larralde A, Cerasuolo D, Bergot E, Fohlen A, Pelage JP. Claudinot A, et al. Among authors: bergot e. J Pers Med. 2023 Nov 12;13(11):1597. doi: 10.3390/jpm13111597. J Pers Med. 2023. PMID: 38003912 Free PMC article.

3

[The place of targeted therapies in the management of non-small cell bronchial carcinoma. Biological mechanisms of bronchial carcinogenesis: towards a better understanding and the development of new therapies].

Zalcman G, Richard N, Madelaine J, Bergot E. Zalcman G, et al. Among authors: bergot e. Rev Mal Respir. 2006 Nov;23(5 Pt 3):16S123-16S130. Rev Mal Respir. 2006. PMID: 17268349 Review. French.

4

[Primitive metastasizing bronchial carcinoid with long survival].

Bouvier N, Zengerling V, Halley A, Le Pennec V, Le Rochais JP, Madelaine J, Galateau-Salle F, Bergot E, Zalcman G. Bouvier N, et al. Among authors: bergot e. Rev Mal Respir. 2007 Jan;24(1):63-8. Rev Mal Respir. 2007. PMID: 17268367 French.

5

[New biological treatments for lung cancer].

Zalcman G, Richard N, Bergot E. Zalcman G, et al. Among authors: bergot e. Rev Pneumol Clin. 2007 Feb;63(1):20-8. doi: 10.1016/s0761-8417(07)90085-1. Rev Pneumol Clin. 2007. PMID: 17457280 Review. French.

6

[Management of malignant pleural effusion].

Zalcman G, Lechapt E, Bergot E. Zalcman G, et al. Among authors: bergot e. Rev Prat. 2007 Mar 15;57(5):513-23. Rev Prat. 2007. PMID: 17583136 Review. French.

7

[DNA Chips in thoracic oncology: molecular diagnosis and the definition of new therapeutic targets, a revolution in progress].

Bergot E, Zalcman G. Bergot E, et al. Rev Mal Respir. 2007 Sep;24(7):821-4. doi: 10.1016/s0761-8425(07)91383-2. Rev Mal Respir. 2007. PMID: 17925663 French. No abstract available.

8

[Epidemiology, molecular biology, diagnostic and therapeutic strategy of malignant pleural mesothelioma in 2007 - an update].

Porret E, Madelaine J, Galateau-Sallé F, Bergot E, Zalcman G. Porret E, et al. Among authors: bergot e. Rev Mal Respir. 2007 Oct;24(8 Pt 2):6S157-64. Rev Mal Respir. 2007. PMID: 18235409 Review. French.

9

[Mechanisms of action of targeted therapies... and mechanisms of resistance].

Bergot E, Richard N, Zalcman G. Bergot E, et al. Rev Mal Respir. 2007 Oct;24(8 Pt 2):6S180-7. Rev Mal Respir. 2007. PMID: 18235412 Review. French.

10

Sarcoidosis.

Bergot E, Paparel P, Zalcman G. Bergot E, et al. N Engl J Med. 2008 Mar 27;358(13):1404; author reply 1404-5. N Engl J Med. 2008. PMID: 18376441 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters